Back
Rate this talk
Your peers have not rated this talk yet.
10-minute watch | Talk 5 of 7

EHA: Tracing the steps to CAR T and beyond

What are the steps to CAR T-cell infusion?

Dr Nicolaus Kröger, Dr Robin Sanderson
SYMPOSIUM
EHA

Dr Robin Sanderson
King’s College Hospital NHS Foundation Trust, London, UK

Prof. Nicolaus Kröger
University Hospital Hamburg-Eppendorf, Hamburg, Germany

Through the discussion of a case study, Dr Robin Sanderson, King’s College Hospital NHS Foundation Trust,
London, UK, explores the factors that can impact treatment outcomes in the period that leads to CAR T-cell infusion, with Prof. Nicolaus Kröger, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Read more

Talks in this series

Dr Sridhar Chaganti , Prof. Nicholas Kröger, Dr Robin Sanderson and Dr Gloria Iacoboni present at EHA (Tracing the steps to CAR T and beyond)
1-minute watch | Talk 1 of 7
EHA: Tracing the steps to CAR T and beyond
Series trailer
Dr Sridhar Chaganti , Prof. Nicholas Kröger, Dr Robin Sanderson and Dr Gloria Iacoboni present at EHA (Tracing the steps to CAR T and beyond)
1-minute watch
EHA: Tracing the steps to CAR T and beyond

Series trailer

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch | Talk 2 of 7
Welcome and introduction
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch

Welcome and introduction

Dr Sridhar Chaganti

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch | Talk 3 of 7
Treatment selection in 2L DLBCL
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch

Treatment selection in 2L DLBCL

Dr Sridhar Chaganti

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
7-minute watch | Talk 4 of 7
How do you identify the appropriate CAR T patient?
Dr Nicolaus Kröger, Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
7-minute watch

How do you identify the appropriate CAR T patient?

Dr Nicolaus Kröger, Dr Sridhar Chaganti

Dr Robin Sanderson presents at EHA (Tracing the steps to CAR T and beyond)
10-minute watch | Talk 5 of 7
What are the steps to CAR T-cell infusion?
Dr Nicolaus Kröger, Dr Robin Sanderson
Dr Robin Sanderson presents at EHA (Tracing the steps to CAR T and beyond)
10-minute watch

What are the steps to CAR T-cell infusion?

Dr Nicolaus Kröger, Dr Robin Sanderson

Dr Gloria Iacoboni presents at EHA (Tracing the steps to CAR T and beyond)
16-minute watch | Talk 6 of 7
How should we manage our patients post CAR T?
Dr Gloria Iacoboni, Dr Nicolaus Kröger
Dr Gloria Iacoboni presents at EHA (Tracing the steps to CAR T and beyond)
16-minute watch

How should we manage our patients post CAR T?

Dr Gloria Iacoboni, Dr Nicolaus Kröger

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch | Talk 7 of 7
Summary and close
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch

Summary and close

Dr Sridhar Chaganti

Dr Sridhar Chaganti , Prof. Nicholas Kröger, Dr Robin Sanderson and Dr Gloria Iacoboni present at EHA (Tracing the steps to CAR T and beyond)
1-minute watch | Talk 1 of 7
EHA: Tracing the steps to CAR T and beyond
Series trailer
Dr Sridhar Chaganti , Prof. Nicholas Kröger, Dr Robin Sanderson and Dr Gloria Iacoboni present at EHA (Tracing the steps to CAR T and beyond)
1-minute watch
EHA: Tracing the steps to CAR T and beyond

Series trailer

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch | Talk 2 of 7
Welcome and introduction
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch

Welcome and introduction

Dr Sridhar Chaganti

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch | Talk 3 of 7
Treatment selection in 2L DLBCL
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch

Treatment selection in 2L DLBCL

Dr Sridhar Chaganti

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
7-minute watch | Talk 4 of 7
How do you identify the appropriate CAR T patient?
Dr Nicolaus Kröger, Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
7-minute watch

How do you identify the appropriate CAR T patient?

Dr Nicolaus Kröger, Dr Sridhar Chaganti

Dr Robin Sanderson presents at EHA (Tracing the steps to CAR T and beyond)
10-minute watch | Talk 5 of 7
What are the steps to CAR T-cell infusion?
Dr Nicolaus Kröger, Dr Robin Sanderson
Dr Robin Sanderson presents at EHA (Tracing the steps to CAR T and beyond)
10-minute watch

What are the steps to CAR T-cell infusion?

Dr Nicolaus Kröger, Dr Robin Sanderson

Dr Gloria Iacoboni presents at EHA (Tracing the steps to CAR T and beyond)
16-minute watch | Talk 6 of 7
How should we manage our patients post CAR T?
Dr Gloria Iacoboni, Dr Nicolaus Kröger
Dr Gloria Iacoboni presents at EHA (Tracing the steps to CAR T and beyond)
16-minute watch

How should we manage our patients post CAR T?

Dr Gloria Iacoboni, Dr Nicolaus Kröger

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch | Talk 7 of 7
Summary and close
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
2-minute watch

Summary and close

Dr Sridhar Chaganti

Interested in this topic?

Find more like this

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.